Gujarat Terce Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

17.35 -0.54 ▼-3.0%

24 March 2023, 04:01:00 PM
Volume: 8,397

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gujaratterce.com
Market Cap 12.87 Cr.
Enterprise Value(EV) 18.50 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -5.57 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 31.87 Trailing Twelve Months Ending 2022-12
Book Value / Share 8.16 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.13 Calculated using Price: 17.35
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.74 Cr. 7,420,300 Shares
FaceValue 10
Company Profile
Gujarat Terce Laboratories is engaged in the manufacturing of tablets, capsules, syrup and injections pertaining to the product group, pharmaceutical formulations and ayurvedic medicines. The company is selling its product in the domestic as well as international market.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.02%
1 Week
+13.40%
1 Month
-1.98%
3 Month
-0.57%
6 Month
-15.37%
1 Year
-26.33%
2 Year
+122.44%
5 Year
+51.79%
10 Year
+70.94%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.22 0.83 -6.30 -0.15 2.65 4.07 2.52 -26.85 10.77
Return on Capital Employed (%) 3.80 3.62 0.88 1.93 3.96 5.38 5.77 -16.40 8.31
Return on Assets (%) 0.94 0.35 -2.66 -0.06 1.26 2.23 1.33 -11.44 3.58

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 11 11 10 10 10 11 11 8 9 6
Non Curr. Liab. 8 8 8 8 2 2 2 2 5 6
Curr. Liab. 7 8 7 6 7 7 9 12 13 16
Minority Int.
Equity & Liab. 26 26 24 24 19 19 22 22 27 27
Non Curr. Assets 10 10 10 11 10 10 10 10 12 11
Curr. Assets 16 17 15 13 10 9 12 12 15 16
Misc. Exp. not W/O
Total Assets 26 26 24 24 19 19 22 22 27 27

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 29 26 25 25 29 31 38 25 40 43
Other Income 0 0 0 0 0 0 0 1 0 0
Total Income 29 27 25 26 29 31 38 26 40 44
Total Expenditure -28 -26 -25 -25 -29 -31 -37 -28 -39 -47
PBIDT 1 1 0 1 1 1 1 -2 1 -3
Interest 0 0 0 0 0 0 0 0 0 -1
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 -1 0 0 0 0 -3 1 -4
Adjusted EPS 0 0 -1 0 0 1 0 -3 1 -6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 4 0 1 0 0 5 -1 -2 0 0
Cash Fr. Inv. -1 0 0 0 0 1 0 0 0 -2
Cash Fr. Finan. -2 -1 -1 -1 0 -5 0 2 2 2
Net Change 1 -1 1 -1 0 0 -1 0 1 -1
Cash & Cash Eqvt 2 1 2 0 1 1 0 0 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 35.74 35.74 35.85 36.22 36.22 36.22 36.22 36.22 36.22
Public 64.26 64.26 64.15 63.78 63.78 63.78 63.78 63.78 63.78
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 07 Mar 2023
Appointment of Company Secretary and Compliance Officer
Appointment of Mrs. Ripal Sachinkumar Sukhadiya as the Company Secretary & Compliance Officer of the Company w.e.f 06th March 2023.
Wed, 08 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI ((LODR) Regulations 2015 this is to inform you that the mentioned share certificate has been reported to be lost. The holder of these shares has requested us to issue duplicate share certificate in lieu of original.
Wed, 08 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI ((LODR) Regulations 2015 this is to inform you that the mentioned share certificate has been reported to be lost. The holder of these shares has requested us to issue duplicate share certificate in lieu of original.

Technical Scans View Details >>

Fri, 24 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 233,407.31 972.80 -0.5%
Divi's Laboratories Ltd. 74,570.12 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. 74,317.23 4,462.75 +0.3%
Cipla Ltd. 70,787.11 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. 61,428.40 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. 51,367.56 1,517.75 -0.9%
Zydus Lifesciences Ltd. 48,636.41 480.50 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 55.42 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.11 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.39 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 26.83 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.33 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.81 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.60 480.50 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.22 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.38 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 3.12 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.82 480.50 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.50 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.50 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.50 -0.4%

FAQ's On Gujarat Terce Laboratories Ltd.

What is Guj. Terce Lab share price?
Can I buy Guj. Terce Lab shares now?
What is the Market Cap of Guj. Terce Lab?
What are the key metrics to analyse Guj. Terce Lab?
What is the 52 Week High and Low of Guj. Terce Lab?
What is the trend of Guj. Terce Lab share price?